Senores Pharmaceuticals, a globally focused, research-driven pharmaceutical company, is set to launch its IPO from December 20 to 24, 2024. The company specializes in the development and manufacturing of a diverse range of pharmaceutical products, with a particular focus on regulated markets like the US and Canada, as well as emerging markets across 43 countries. Senores Pharmaceuticals has established key partnerships with major players in the industry, including Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc. and others.
IPO Details:
- Issue Dates: 20 – 24 December 2024
- Face Value: ₹10 per share
- Fresh Issue: ₹500 crore
- Offer for Sale: 21,00,000 shares
- Listing on: NSE, BSE
- Retail Allocation: 10%
- Minimum Bid: Details coming soon
- Issue Price: To be announced
Senores Pharmaceuticals has registered 182 products and has filed for 245 additional product registrations. The company also manufactures critical care injectables and active pharmaceutical ingredients (APIs).
Financial Performance & Valuations:
Senores Pharmaceuticals has demonstrated strong growth in its financials:
- FY 2024 Revenue: ₹214.52 crore
- FY 2024 Net Income: ₹32.71 crore
- EPS: ₹12.21
- RONW: 23.60%
- ROCE: 11.73%
- Debt/Equity Ratio: 1.07
IPO Objectives: The funds raised from the IPO will be utilized for various purposes, including:
- Capital expenditure for a new sterile injection manufacturing facility in Atlanta (₹107 crore)
- Repayment of borrowings from subsidiaries (₹93.7 crore)
- Working capital requirements (₹102.74 crore)
- Inorganic growth through acquisitions and strategic initiatives (amount unspecified)
Senores Pharmaceuticals vs Peers: While Senores Pharmaceuticals stands out for its strong revenue growth, its competitors such as Ajanta Pharma and Alembic Pharmaceuticals have higher revenues and established market presence. However, Senores’ focus on specialty and complex pharmaceutical products sets it apart in the industry.
IPO Timeline:
- IPO Opening Date: 20 December 2024
- IPO Closing Date: 24 December 2024
- Finalization of Basis of Allotment: 26 December 2024
- Refunds Initiation: 27 December 2024
- Shares Transfer to Demat Accounts: 27 December 2024
- Listing Date: 30 December 2024
How to Apply for Senores Pharmaceuticals IPO: Investors can apply for the IPO through ASBA (Applications Supported by Blocked Amount) or by using UPI through their stock brokers. Paper applications can also be submitted at the broker’s office.
Senores Pharmaceuticals IPO Allotment Status: The allotment status will be available on Link Intime’s website. The final allotment list will be released on 26 December 2024.
Should You Subscribe to Senores Pharmaceuticals IPO? With impressive growth potential and a solid financial track record, Senores Pharmaceuticals presents an interesting opportunity for investors. However, it’s important to compare it with its peers and consider your investment goals before deciding to invest.
Stay tuned for more updates as the IPO opens on 20 December 2024!
